A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus

https://doi.org/10.1016/j.psyneuen.2008.12.010Get rights and content

Summary

There is emerging evidence from healthy individuals, as well as direct and indirect evidence from psychiatric and neurological patients with disease-related hippocampal atrophy, linking the cortisol awakening response (CAR) to hippocampal volume. Type 2 diabetes mellitus (T2DM) is a metabolic disease that is also accompanied by hippocampal atrophy, and therefore can serve as a model for ascertaining the relationship between CAR and hippocampal volume. We contrasted a group of 18 individuals with T2DM with 12 matched controls on MRI-based hippocampal volume and salivary diurnal cortisol profile including CAR. Individuals with T2DM had smaller hippocampal volumes and exhibited a blunting of the CAR relative to controls, while diurnal cortisol was not affected. Across all subjects, fasting insulin and hippocampal volume were associated with the CAR, independent of diagnosis. Our findings support the hypothesis that hippocampal integrity is an important predictor of the CAR.

Introduction

In recent years, the cortisol awakening response (CAR) has been increasingly used as an index of adrenocortical activity in psychiatric and non-psychiatric populations. The characteristics of the CAR are well-described; it represents a rise in cortisol of 50–75% with peak levels about 30 min post-wake-up (Clow et al., 2004). However, the underlying regulatory mechanisms for this post-wake-up response remain unclear. More is known about the impact of various factors, such as age, gender, oral contraceptive use, menstrual cycle phase, wake-up time, and smoking status on the CAR, but results have not been uniform. Briefly, increasing age has been associated with an attenuated CAR (Kudielka and Kirschbaum, 2003), albeit not consistently (Pruessner et al., 1997). There are some gender-based differences in CAR, with women maintaining higher cortisol levels after peak levels have been reached (Pruessner et al., 1997, Wuest et al., 2000, Schlotz et al., 2004). However, menstrual cycle phase and oral contraceptive use do not seem to impact the CAR (Kirschbaum et al., 1999). Findings with respect to the impact of wake-up time on CAR appear mixed, with earlier wake-up times correlating with a higher CAR in some (Kudielka and Kirschbaum, 2003, Federenko et al., 2004), but not all (Pruessner et al., 1997, Hucklebridge et al., 1999) studies. Similarly, smoking has been shown to either have no effect on the CAR (Pruessner et al., 1997) or result in an increased CAR (Badrick et al., 2007). Please see Fries et al. (in press) for a review on the CAR.

In addition to the above-mentioned factors associated with the CAR, in the last few years a link between hippocampal integrity and the CAR has been postulated. For example, among healthy individuals smaller hippocampal volume is associated with a reduced CAR (Pruessner et al., 2005, Pruessner et al., 2007). Furthermore, patients with selective hippocampal lesions (Buchanan et al., 2004) and patients with severe global amnesia caused by damage in the frontal and temporal lobes (Wolf et al., 2005) exhibit a blunted CAR. However, the study of hippocampal lesion patients failed to find a direct association between hippocampal volume (assessed with MRI) and the CAR, and the study of global amnesia patients did not assess hippocampal volumes.

In psychiatric conditions such as depression and PTSD, both hippocampal volume loss (Videbech and Ravnkilde, 2004, Smith, 2005) and blunting of the CAR (Rohleder et al., 2004, Huber et al., 2006) have been reported. However, none of these studies conducted both CAR and hippocampal volume assessments in the same set of study subjects, which does not allow any comment on possible associations. Nevertheless, by considering the results of studies in healthy individuals together with those of lesion populations and the indirect evidence among psychiatric populations, some authors have suggested that hippocampal integrity per se may be crucial for an intact CAR. However, it remains unclear how milder forms of hippocampal atrophy, as have been described in type 2 diabetes mellitus (T2DM), impact on the CAR.

T2DM is a metabolic disorder, characterized by insulin resistance and hyperglycemia (Quinn, 2002). Risk factors for developing T2DM include age (Panagiotakos et al., 2008), physical inactivity (Dyck et al., 2008), obesity (Ferrannini et al., 1997) and genetic predisposition (Busch and Hegele, 2001). T2DM is associated with lipid abnormalities (Goldberg and Capuzzi, 2001), hypertension (Bloomgarden, 2001) and impairments in cognition (Awad et al., 2004). Importantly, there are two studies in the literature reporting hippocampal volume loss in T2DM (den Heijer et al., 2003, Gold et al., 2007). Given the role of the hippocampus in HPA axis feedback regulation (Jacobson and Sapolsky, 1991) and the close link between cortisol and glucose metabolism (Khani and Tayek, 2001), it is not all that surprising there is also some indication for HPA axis disturbances in T2DM, although the order of events remains unclear. Both unstimulated plasma levels (Lee et al., 1999), as well as dexamethasone-suppressed cortisol levels (Bruehl et al., 2007) have been shown to be elevated in T2DM, although this has not been uniformly reported (Andrews et al., 2002). In addition, elevated evening free cortisol salivary levels have been observed in T2DM relative to controls (Liu et al., 2005). Therefore, the purpose of this study was to ascertain the CAR and diurnal salivary cortisol profile in T2DM and determine whether it is associated to hippocampal volume.

Section snippets

Participants and procedure

30 volunteers (18 diabetics, 12 non-diabetic controls) participated in the study. They were referred by collaborating endocrinologists or responded to advertisements on the Internet. None had evidence of neurological, medical (except dyslipidemia, or hypertension), or psychiatric conditions. Head trauma, depression, and substance abuse were exclusion criteria. All participants came to our laboratory on 3 separate days and received a physical examination (see Bruehl et al., 2007) and an MRI scan

Medical

Diabetic participants tended to be younger (p = 0.076) and, as expected had significantly higher fasting glucose and insulin levels as well as higher percent HbA1c, greater BMI, and more lipid abnormalities than controls (all p < 0.05). Please refer to Table 1.

Salivary cortisol: CAR profile and diurnal profile

ANOVA of the CAR profile revealed a significant main effect of time (F = 5.063, p = 0.003), indicative of cortisol rhythmicity. Furthermore, we found a significant interaction of time and diagnosis for the CAR profile (F = 4.720, p = 0.004). The CAR

Discussion

In this first report of both CAR and hippocampal volume among individuals with T2DM and controls, we detected a blunting of the CAR, with preservation of diurnal rhythm, in participants with T2DM. In addition, as we had hypothesized, we found reduced hippocampal volume among individuals with T2DM and that reduction in hippocampal volume was associated with duration of T2DM, and long-term glycemic control (HbA1c). Furthermore, across all participants, insulin levels and hippocampal volume

Role of funding sources

This study was supported by grants DK 064087, P30-AG-08051 and NCRR M01 RR00096 from the National Institutes of Health, USA.

Conflict of interest

The authors have no real or apparent conflict of interest.

Acknowledgements

We thank Prof. Clemens Kirschbaum for conducting the cortisol assays.

References (52)

  • B.M. Kudielka et al.

    Awakening cortisol responses are influenced by health status and awakening time but not by menstrual cycle phase

    Psychoneuroendocrinology

    (2003)
  • N. Lasikiewicz et al.

    Exploration of basal diurnal salivary cortisol profiles in middle-aged adults: associations with sleep quality and metabolic parameters

    Psychoneuroendocrinology

    (2008)
  • J.C. Pruessner et al.

    Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity

    Life Sci.

    (1997)
  • J.C. Pruessner et al.

    Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change

    Psychoneuroendocrinology

    (2003)
  • J.C. Pruessner et al.

    Self-esteem, locus of control, hippocampal volume, and cortisol regulation in young and old adulthood

    Neuroimage

    (2005)
  • M. Pruessner et al.

    The associations among hippocampal volume, cortisol reactivity, and memory performance in healthy young men

    Psychiatry Res.: Neuroimag.

    (2007)
  • J.C. Pruessner et al.

    Deactivation of the limbic system during acute psychosocial stress: evidence from positron emission tomography and functional magnetic resonance imaging studies

    Biol. Psychiatry

    (2008)
  • N. Rohleder et al.

    Hypocortisolism and increased glucocorticoid sensitivity of pro-inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder

    Biol. Psychiatry

    (2004)
  • A. Rojas et al.

    Advanced glycation and endothelial functions: a link towards vascular complications in diabetes

    Life Sci.

    (2004)
  • P. Scheltens et al.

    A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging

    J. Neurol. Sci.

    (1993)
  • I. Wilhelm et al.

    Is the cortisol awakening rise a response to awakening?

    Psychoneuroendocrinology

    (2007)
  • O.T. Wolf et al.

    No morning cortisol response in patients with severe global amnesia

    Psychoneuroendocrinology

    (2005)
  • R.C. Andrews et al.

    Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance

    J. Clin. Endocrinol. Metab.

    (2002)
  • N. Awad et al.

    The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function

    J. Clin. Exp. Neuropsychol.

    (2004)
  • E. Badrick et al.

    The relationship between smoking status and cortisol secretion

    J. Clin. Endocrinol. Metab.

    (2007)
  • Z.T. Bloomgarden

    Diabetes and hypertension

    Diabetes Care

    (2001)
  • Cited by (0)

    View full text